Core Laboratories Inc. $CLB Stock Position Lowered by Fisher Asset Management LLC

Fisher Asset Management LLC cut its stake in shares of Core Laboratories Inc. (NYSE:CLB – Free Report) by 17.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 369,273 shares of the oil and gas company’s stock after selling 78,676 shares during the period. Fisher Asset Management LLC’s holdings in Core Laboratories were worth $3,582,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. State of Wyoming grew its position in Core Laboratories by 267.7% in the 1st quarter. State of Wyoming now owns 4,626 shares of the oil and gas company’s stock valued at $78,000 after buying an additional 3,368 shares during the last quarter. Fifth Third Bancorp increased its stake in Core Laboratories by 2,397.6% in the 1st quarter. Fifth Third Bancorp now owns 11,414 shares of the oil and gas company’s stock valued at $192,000 after buying an additional 10,957 shares during the period. Corient Private Wealth LP acquired a new position in Core Laboratories in the 2nd quarter valued at $141,000. The Manufacturers Life Insurance Company acquired a new position in Core Laboratories in the 2nd quarter valued at $156,000. Finally, AXQ Capital LP purchased a new position in Core Laboratories during the 2nd quarter worth $225,000. 97.81% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently commented on CLB shares. Weiss Ratings cut shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Saturday, August 1st. Finally, Johnson Rice raised shares of Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a report on Thursday, August 13th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $21.00.

Check Out Our Latest Report on Core Laboratories

Core Laboratories Stock Performance

NYSE CLB opened at $8.48 on Tuesday. The company has a current ratio of 2.19, a quick ratio of 1.60 and a debt-to-equity ratio of 0.40. The business’s 50 day moving average is $10.30 and its two-hundred day moving average is $13.36. Core Laboratories Inc. has a 12-month low of $8.44 and a 12-month high of $20.36. The stock has a market capitalization of $388.42 million, a price-to-earnings ratio of 22.31, a PEG ratio of 1.80 and a beta of 1.18.

Core Laboratories (NYSE:CLB – Get Free Report) last issued its earnings results on Wednesday, October 28th. The oil and gas company reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $132.08 million during the quarter, compared to the consensus estimate of $131.87 million. Core Laboratories had a return on equity of 8.94% and a net margin of 3.42%. The company’s revenue for the quarter was down 1.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.22 EPS. Research analysts expect that Core Laboratories Inc. will post 0.56 EPS for the current year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Monday, November 9th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 9th. Core Laboratories’s dividend payout ratio is currently 10.53%.

About Core Laboratories

(Free Report)

Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery.

Read More

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB – Free Report).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.